Phesgo billing units
WebBill Units Bill Units PKG; 50242024501: J9316: Pertuzu, trastuzu, 10 mg: Phesgo: GENENTECH, INC. 10 MG: 15: 1: 180: 180: 50242026001: J9316: Pertuzu, trastuzu, 10 mg: Phesgo: GENENTECH, INC. 10 MG: 10: 1: 120: 120: The ASP crosswalks are maintained by the Division of Data Analysis and Market Based Pricing to support ASP-based Medicare … WebWhat does PHESGO treat? PHESGO ® (pertuzumab, trastuzumab, and hyaluronidase-zzxf) is a prescription medicine approved for use in combination with chemotherapy for:. use prior to surgery (neoadjuvant treatment) in adults with HER2-positive, locally advanced, inflammatory, or early stage breast cancer (tumor is greater than 2 cm in diameter or …
Phesgo billing units
Did you know?
WebSep 15, 2024 · Description. Pertuzumab, trastuzumab, and hyaluronidase-zzxf (Phesgo) is a fixed-dose combination of two (2) monoclonal antibodies, pertuzumab and trastuzumab, that are antagonists of the human epidermal growth factor receptor 2 (HER2). Pertuzumab, trastuzumab, and hyaluronidase-zzxf (Phesgo) is administered subcutaneously by a … Web1,200 mg pertuzumab/600 mg trastuzumab/30,000 units /15 mL: Administer SC over ~8 min; 600 mg pertuzumab/600 mg trastuzumab/30,000 units/10 mL: Administer SC over ~5 min; Sequence of administration. Anthracycline-based regimen (EBC): Administer Phesgo …
WebMar 1, 2024 · PHESGO. PHESGO may harm the unborn baby. You should use effective contraception during treatment with PHESGO and for 7 months after stopping treatment. If you are a male patient taking PHESGO with a female partner who can become pregnant you should use effective contraception during treatment with PHESGO and for 7 months after … WebPHESGO should be administered every 3 weeks 1,2 Loading (initial) dose 1200 mg pertuzumab, 600 mg trastuzumab, 30,000 units hyaluronidase per 15 mL supplied in a single-dose, ready-to-use vial Administer subcutaneously over approximately 8 minutes at …
WebAug 25, 2024 · The initial dose of Phesgo™ is 1,200 mg pertuzumab, 600 mg trastuzumab, and 30,000 units hyaluronidase administered subcutaneously over approximately 8 minutes, followed every 3 weeks by a dose of 600 mg pertuzumab, 600 mg trastuzumab, and … WebJan 1, 2024 · for PHESGO™ (pertuzumab, trastuzumab, and hyaluronidase-zzxf) Breast Cancer The Centers for Medicare & Medicaid Services (CMS) has assigned a permanent J-code for PHESGO effective January 1, 2024. TYPE CODE DESCRIPTION Diagnosis: ICD-10 …
Web• The initial dose of PHESGO is 1,200 mg pertuzumab, 600 mg trastuzumab, and 30,000 units hyaluronidase administered subcutaneously over approximately 8 minutes, followed every 3 weeks by a dose of 600 mg pertuzumab, 600 mg trastuzumab, and 20,000 units …
WebFamiliarize yourself with PHESGO® (pertuzumab / trastuzumab / hyaluronidase-zzfx) dosing and administration in HER2-positive breast cancer. ... 600 milligrams of trastuzumab, and 30,000 units of hyaluronidase. The second formulation is a maintenance dose of 10 milliliters. This ready-to-use vial contains 600 milligrams of pertuzumab, 600 ... corona maske kn95WebJan 1, 2024 · − Phesgo 600 mg (P)/600 mg (T)/20,000 units (hyu) single-dose vial: 1 vial every 21 days B. Max Units (per dose and over time) [HCPCS Unit]: Breast Cancer • Loading dose: 180 billable units for 1 dose • Maintenance dose: 120 billable units every 21 days … corona maske tragen im autoWebPermanently discontinue treatment with PHESGO in patients who experience anaphylaxis or severe injection-related reactions. Medications to treat such reactions, as well as emergency equipment, should be available for immediate use. corona matschig im kopfWebPHESGO is a prescription medicine approved for use in combination with docetaxel in adults who have HER2-positive breast cancer that has spread to different parts of the body (metastatic) and who have not received anti-HER2 therapy or chemotherapy for … corona maske im auto tragenWebThe NDC Packaged Code 50242-245-01 is assigned to a package of 1 vial, single-dose in 1 carton / 15 ml in 1 vial, single-dose of Phesgo, a human prescription drug labeled by Genentech, Inc.. The product's dosage form is injection, solution and is administered via … corona makarskacorona masken im autoWebMar 2, 2024 · Phesgo contains two active substances, pertuzumab and trastuzumab, which are already authorised for treating early and metastatic HER2-positive breast cancer and are available as infusion into a vein.Phesgo is as effective at treating breast cancer as the … corona maske n95